Trans-activation of the DNA-damage signalling protein kinase Chk2 by T-loop exchange

被引:116
作者
Oliver, Antony W.
Paul, Angela
Boxall, Katherine J.
Barrie, S. Elaine
Aherne, G. Wynne
Garrett, Michelle D.
Mittnacht, Sibylle
Pearl, Laurence H.
机构
[1] Inst Canc Res, Canc Res UK, DNA Repair Enzymes Grp, Sect Struct Biol, London SW3 6JB, England
[2] Inst Canc Res, Canc Res UK, Ctr Cell & Mol Biol, London SW3 6JB, England
[3] Inst Canc Res, Haddow Labs, Canc Res UK, Ctr Canc Therapeut, Sutton, Surrey, England
关键词
cancer; CHEK2; CHK2; inhibitor; kinase;
D O I
10.1038/sj.emboj.7601209
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The protein kinase Chk2 (checkpoint kinase 2) is a major effector of the replication checkpoint. Chk2 activation is initiated by phosphorylation of Thr68, in the serine glutamine/threonine-glutamine cluster domain (SCD), by ATM. The phosphorylated SCD-segment binds to the FHA domain of a second Chk2 molecule, promoting dimerisation of the protein and triggering phosphorylation of the activation segment/T-loop in the kinase domain. We have now determined the structure of the kinase domain of human Chk2 in complexes with ADP and a small-molecule inhibitor debromohymenialdisine. The structure reveals a remarkable dimeric arrangement in which T-loops are exchanged between protomers, to form an active kinase conformation in trans. Biochemical data suggest that this dimer is the biologically active state promoted by ATM-phosphorylation, and also suggests a mechanism for dimerisation-driven activation of Chk2 by trans-phosphorylation.
引用
收藏
页码:3179 / 3190
页数:12
相关论文
共 38 条
  • [1] Phosphorylation of threonine 68 promotes oligomerization and autophosphorylation of the Chk2 protein kinase via the forkhead-associated domain
    Ahn, JY
    Li, XH
    Davis, HL
    Canman, CE
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (22) : 19389 - 19395
  • [2] Ahn JY, 2000, CANCER RES, V60, P5934
  • [3] Chk2 kinase - A busy messenger
    Bartek, J
    Falck, J
    Lukas, J
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2001, 2 (12) : 877 - 886
  • [4] Chk1 and Chk2 kinases in checkpoint control and cancer
    Bartek, J
    Lukas, J
    [J]. CANCER CELL, 2003, 3 (05) : 421 - 429
  • [5] PHOSPHOTRANSFERASE AND SUBSTRATE BINDING MECHANISM OF THE CAMP-DEPENDENT PROTEIN-KINASE CATALYTIC SUBUNIT FROM PORCINE HEART AS DEDUCED FROM THE 2.0 ANGSTROM STRUCTURE OF THE COMPLEX WITH MN2+ ADENYLYL IMIDODIPHOSPHATE AND INHIBITOR PEPTIDE PKI(5-24)
    BOSSEMEYER, D
    ENGH, RA
    KINZEL, V
    PONSTINGL, H
    HUBER, R
    [J]. EMBO JOURNAL, 1993, 12 (03) : 849 - 859
  • [6] The 1.7 Å crystal structure of human cell cycle checkpoint kinase Chk1:: Implications for Chk1 regulation
    Chen, P
    Luo, C
    Deng, YL
    Ryan, K
    Register, J
    Margosiak, S
    Tempczyk-Russell, A
    Nguyen, B
    Myers, P
    Lundgren, K
    Kan, CC
    O'Connor, PM
    [J]. CELL, 2000, 100 (06) : 681 - 692
  • [7] Targeting the cell division cycle in cancer: CDK and cell cycle checkpoint kinase inhibitors
    Collins, I
    Garrett, MD
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2005, 5 (04) : 366 - 373
  • [8] Inhibition of the G2 DNA damage checkpoint and of protein kinases Chk1 and Chk2 by the marine sponge alkaloid debromohymenialdisine
    Curman, D
    Cinel, B
    Williams, DE
    Rundle, N
    Block, WD
    Goodarzi, AA
    Hutchins, JR
    Clarke, PR
    Zhou, BB
    Lees-Miller, SP
    Andersen, RJ
    Roberge, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (21) : 17914 - 17919
  • [9] Crystal structure of glycogen synthase kinase 3β:: Structural basis for phosphate-primed substrate specificity and autoinhibition
    Dajani, R
    Fraser, E
    Roe, SM
    Young, N
    Good, V
    Dale, TC
    Pearl, LH
    [J]. CELL, 2001, 105 (06) : 721 - 732
  • [10] Coot:: model-building tools for molecular graphics
    Emsley, P
    Cowtan, K
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2004, 60 : 2126 - 2132